Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Barinthus Biotherapeutics (BRNS) Total Liabilities (2020 - 2025)

Historic Total Liabilities for Barinthus Biotherapeutics (BRNS) over the last 6 years, with Q3 2025 value amounting to $24.6 million.

  • Barinthus Biotherapeutics' Total Liabilities fell 1569.73% to $24.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.6 million, marking a year-over-year decrease of 1569.73%. This contributed to the annual value of $30.2 million for FY2024, which is 974.52% up from last year.
  • As of Q3 2025, Barinthus Biotherapeutics' Total Liabilities stood at $24.6 million, which was down 1569.73% from $27.1 million recorded in Q2 2025.
  • Over the past 5 years, Barinthus Biotherapeutics' Total Liabilities peaked at $34.4 million during Q3 2023, and registered a low of $9.9 million during Q2 2021.
  • For the 5-year period, Barinthus Biotherapeutics' Total Liabilities averaged around $26.2 million, with its median value being $28.2 million (2021).
  • Per our database at Business Quant, Barinthus Biotherapeutics' Total Liabilities plummeted by 4768.36% in 2021 and then skyrocketed by 22707.98% in 2022.
  • Quarter analysis of 5 years shows Barinthus Biotherapeutics' Total Liabilities stood at $28.2 million in 2021, then fell by 4.08% to $27.0 million in 2022, then increased by 1.88% to $27.5 million in 2023, then rose by 9.75% to $30.2 million in 2024, then fell by 18.39% to $24.6 million in 2025.
  • Its Total Liabilities was $24.6 million in Q3 2025, compared to $27.1 million in Q2 2025 and $26.4 million in Q1 2025.